Advocates for Human Potential, Inc.

A Bureau of Justice Assistance (BJA) funded program provided by Advocates for Human Potential, Inc. (AHP)
in partnership with Treatment Alternatives for Safe Communities (TASC) and AdCare Criminal Justice Services (ACJS).

 





RSAT FUNDING HAS JUST BEEN INCREASED FROM $14 TO $30 MILLION!

Funding for Comprehensive Opioid Abuse Programs (COAP), another BJA grant program, increased from $13 to $145 million. Note: Correctional programs may be eligible, especially those addressing reentry and pretrial treatment!



 


Promising Practices Guidelines for Residential Substance Abuse Treatment






A Comprehensive Listing of What States Cover for Substance
Use Disorder, including Medications






New Manual on
Health Literacy

Once they obtain health coverage, RSAT participants need to maximize the benefits offered in terms of preventive and primary care to promote both better physical and behavioral health.









Prison/Jail Medication Assisted Treatment Manual

Once you've seen the video, read the details of these exemplary programs.






 

Other Prison/Jail MAT Manuals

Rhode Island Vivitrol Manual
Rhode Island Suboxone SOP
Rhode Island Distribution of Suboxone Protocol
Kentucky MAT Manual
Massachusetts Department of Correction Medication Assisted Treatment Re-Entry Initiative (MATRI) Clinical Guidelines
Vermont MAT for Inmates: Work Group Evaluation Report and Recommendations
New Hampshire DOC MAT and Naltrexone Oral Augmentation Clinical Guidelines
Department of Vermont Health Access, Managed Care Entity, Vermont Buprenorphine Clinical Practice Guidelines, August 2015


Resolution of National Sheriffs’ Association on MAT
ACA and ASAM Joint Policy on OUD Rx in Justice System




Correctional MAT Videos




SAMHSA Video: Benefits and Cost Savings of MAT
Services in a Correctional Setting

This video features presentations from Jon Berge, SAMHSA, Mark Parrino, American Association for the Treatment of Opioid Dependence, Andrew Klein, RSAT TTA and Advocates for Human Potential, Kathleen Maurer, Connecticut DOC, and Kevin Pangburn, Kentucky DOC.
https://www.youtube.com/watch?v=I18PfJ6k8G4&t=3160s


Montgomery County Corrections

Montgomery County, Maryland Department of Correction and Rehabilitation
video on that institution’s MAT Program
https://www.youtube.com/user/montgomerycountyDOCR


Massachusetts Department of Corrections

https://www.youtube.com/watch?v=BlCGe6kaCxk

Brief descriptions of some Prison and Jail MAT Programs

Kentucky Prison, Massachusetts Prison, Philadelphia Jail, Rhode Island Prison,
West Virginia Prison, Wisconsin, Sacramento Jail, New Haven and Bridgeport Jails (Administered by state DOC), Kenton County, Kentucky Jail, Montgomery County, Maryland Jail, Barnstable County, Massachusetts Jail, Middlesex County, New York City Jail, and Salt Lake City Jail


Pennsylvania’s Medication Assisted Treatment (MAT) Pilot Program For Justice-Involved Individuals


MASS DOC MATRI PROGRAM


Report on New Hampshire DOC MAT in Custody
Naltrexone Program








RSAT Jail Program Tour






What Inmates Tell us About RSAT





HOLD THE DATE!

RSAT Annual Meeting
September 5-7, 2018

Washington, D.C.

This year we will be part of a larger meeting including other BJA grantees also addressing the opioid epidemic.








  • NASTAD - Pharmaceutical Company Patient Assistance and Cost-sharing Assistance Programs: Hepatitis

    This NASTAD website describes Patient Assistance and Cost-sharing Assistance Programs for medication to treat Hepatitis for people with low incomes who do not qualify for Medicaid, Medicare or AIDS Drug Assistance Programs.

  • Pre-Release Injectable Naltrexone Shown to Improve Post-Release HIV treatment

    Jail populations have the highest rates of opioid use disorder and HIV in the country. A new study finds that those released on injectable naltrexone are more likely to maintain or improve their HIV viral load suppression, indicating all important HIV medication compliance. Typically, the period of time right after persons are released from jail is chaotic, associated with both opioid overdoses and loss of HIV care. In the Yale study, incarcerated people were provided either injectable naltrexone or a placebo during the transition back to their communities. Following 93 people for six months each between 2010 and 2016, the researchers found that a greater proportion of the people who received extended-release naltrexone ended up getting HIV treatment as well. Said co-author, “This is the first study to show in a randomized, double-blinded control trial that an FDA-approved medication used to treat opioid use disorder — naltrexone — can improve viral load suppression.” Previously, the same lab had found similar results for persons released on buprenorphine, but that study did not involve a randomized control trial. Researchers suggested that the Department of Health and Human Services, the World Health Organization and the International AIDS Society should all include the use of medication to prevent opioid use as a method to maintain viral load suppression for people who also have opioid-use disorder. Springer, S. A. et. al. (2018). Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial, Journal of Acquired Immune Deficiency Syndromes. 78(1):43-53

  • Medicare Doesn’t Cover Methadone for MAT

    Brief summary of Medicare coverage and challenges faced by those on methadone maintenance when they reach 65 years.

  • The Opioid Epidemic and Medicaid's Role in Facilitating Access to Treatment

    Among nonelderly adults with opioid addiction, those with Medicaid were twice as likely as those with private insurance or no insurance to have received treatment in 2016. Medicaid facilitates access to treatment by covering numerous inpatient and outpatient treatment services, as well as medications prescribed as part of medication-assisted treatment. States use Medicaid Section 1115 waivers and other program authorities to expand treatment options for enrollees with opioid addiction. This study shows the critical importance of enrolling RSAT participants in Medicaid if eligible.

  • California Reentry Guide

    Reentry Health Policy Project’s Meeting the Serious Health and Behavioral Needs of Prison and Jail Inmates Returning to the Community identifies state and county-level policies and practices to deliver effective care to people who are reentering California communities. It focuses on the following issue areas: 1) Eligibility establishment to receive care; 2) Care coordination; 3) Maximizing federal financial participation, primarily through the Affordable Care Act; 4) Release of information; 5) Residential and outpatient treatment capacity; 6) Housing; and 7) Evaluation.


  • Opioid Pain Pills Still Top Selling Drug in South, Midwest

    According to a national study of prescriptions, Hydrocodone, opioid pain medication, is the most prescribed medication in 10 states, mainly in the South and Midwest (AK, AL, GA, ID, IL, IN, MS, NC, NE, OK). As recently as 2012, hydrocodone was the most widely prescribed medication in the country. Since then, hydrocodone prescriptions have fallen by over a third and it now ranks 4th nationwide. The most prescribed medication in Tennessee, on the other hand, is Suboxone (buprenorphine with naloxone), an opioid treatment medication. In 2012, doctors in Tennessee wrote 1.4 opioid prescriptions for every citizen in that state, the second highest rate in the country. The state then moved aggressively to shutdown pill mills and expand access to addiction treatment, accounting for its high rate of Suboxone prescriptions. Prescriptions for opioid pain medication dropped 12% in Tennessee but overdose deaths continue to climb due to heroin and fentanyl use. Tennessee is currently adopting measures to rein in the over prescription of Suboxone.

  • Transforming hurt into healing: ‘Building Resilience’ program thrives in Corcoran

    This article describes a California prison program to address trauma in a maximum security men’s prison. A study at Rutgers found that one in six male inmates studied reported being physically or sexually abused as a child, and many more witnessed traumatic events. The described program began in 2016 at California State Prison-Corcoran (COR), which has seen real results from the program that challenges men to look not only at the trauma that has happened to them, but also on the pain they have caused others.

  • Promising Practices Archive


Information on Effective Cognitive Behavioral Approaches


MAT Resources and Research


Substance Abuse Facilities-Opioid Treatment Services,
SAMHSA Feb. 2017

Map of Opioid Treatment Providers

SAMHSA’s Pocket Guide to Medication-assisted Treatment for Opioid Use Disorders

Link to PDF:

http://store.samhsa.gov/shin/content//SMA16-4892PG/SMA16-4892PG.pdf

Link to SAMHSA Store page on this item:

http://store.samhsa.gov/product/Medication-Assisted-Treatment-of-Opioid-Use-Disorder-Pocket-Guide/Most-Popular/SMA16-4892PG?sortByValue=4

FDA Newly Issued ‘Boxed’ warning on the dangers of combining opioids and benzodiazepines

Link to the FDA Drug Safety Announcement:

http://www.fda.gov/Drugs/DrugSafety/ucm518473.htm

Link to PDF of Safety Announcement:

http://www.fda.gov/downloads/Drugs/DrugSafety/UCM518672.pdf





Tennessee Health Department Finds Some Overdose Deaths Associated With Buprenorphine


Opioid Treatment Drugs Have Similar Outcomes Once Patients Initiate Treatment

This NIDA study compares buprenorphine/naloxone combination to extended release naltrexone. It is the second that now finds the two medications work equally well although one is an opioid substitute and the other an opioid (and alcohol) blocker.



 
Participate in our forum!

Our state wants to expand drug treatment in our prisons. We currently have a RSAT program in one of our facilities. As required, it is a six-month program and offers a modified therapeutic community treatment program. With non-federal funding, would it be better to provide shorter programs that can reach more individuals in need? Do other treatment modalities work as well as therapeutic communities for drug treatment in prisons?